The type I IFNs driven by activation of cGAS-STING signaling pathway play a pivotal role in immune modulation for it not only amplifies the antigen-presenting function but also boosts CD8+ T cells activity, supporting anti-tumor immunity. This evidence concerns the gene STING1 and neoplasm.